The Usability of Drug Error Reduction Software (DERS) in Smart Infusion Pumps: Exploring Programming Constraints on Nurse Workarounds and Patient Safety

Summary

This study looks at how nurses use smart infusion pumps to give medications. Smart infusion pumps are devices that send medicine into a vein. They also have safety measures, called Drug Error Reduction Software (DERS), that helps prevent dosing mistakes.
The goal of this study is to see how easy or hard these pumps are to use. We want to understand the problems nurses may have when setting up the pump and how they react to safety alerts.
The study includes two practice tasks where nurses program the Baxter Sigma Spectrum pump, and an interview about their experiences. No real patients are involved.
By learning from nurses, we hope to find ways to make these pumps easier to use and improve patient safety.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 75

Accepts healthy participants: Yes

Inclusion criteria:

To participate in this study, you must:
1) currently be a student nurse, registered nurse (RN), or Licensed Nurse Practitioner (LNP)
2) have at least six months of experience with the Baxter Sigma Spectrum pump in medical-surgical settings
3) be fluent in English

Exclusion criteria:

You are not eligible to participate if you:
1) are retired or non-practicing
2) do not have at least six months of experience with the Baxter Sigma Spectrum pump in medical-surgical settings
4) are not fluent in English

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

If you are interested in participating or would like to know more about the study, please contact Andrea Richardsen at andrea.richardsen@ucalgary.ca

Principal investigator:

Junho Park

Clinical trial:

No

REB-ID:

REB26-0212